Oncology guidelines
90 current Oncology guidelines from national agencies, European societies, and HTA bodies, across 14 source groups. eUvidence anchors Oncology answers to this guidance; each entry links to the issuing body’s own page.
European societies· 29
- ESMO Clinical Practice Guideline Express Update on the management of epithelial ovarian cancer
ESMO · European Society for Medical Oncology · 2026
- Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO · European Society for Medical Oncology · 2025
- Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO · European Society for Medical Oncology · 2025
- ESMO Clinical Practice Guideline Express Update on the management of metastatic pancreatic cancer
ESMO · European Society for Medical Oncology · 2025
- Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO · European Society for Medical Oncology · 2025
- Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO · European Society for Medical Oncology · 2025
- Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO · European Society for Medical Oncology · 2024
- Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO · European Society for Medical Oncology · 2024
- ESMO Clinical Practice Guideline interim update on new targeted therapies in the first line and at relapse of chronic lymphocytic leukaemia
ESMO · European Society for Medical Oncology · 2024
- Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO · European Society for Medical Oncology · 2024
- Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO · European Society for Medical Oncology · 2023
- Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO · European Society for Medical Oncology · 2023
- Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO · European Society for Medical Oncology · 2023
- Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO · European Society for Medical Oncology · 2023
- Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO · European Society for Medical Oncology · 2023
- Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO · European Society for Medical Oncology · 2022
- Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO · European Society for Medical Oncology · 2022
- Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO · European Society for Medical Oncology · 2022
- Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO · European Society for Medical Oncology · 2022
- Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO · European Society for Medical Oncology · 2022
- Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
ESMO · European Society for Medical Oncology · 2021
- ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
ESMO · European Society for Medical Oncology · 2021
- Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
EHA · European Hematology Association · 2021
- EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
EANO · European Association of Neuro-Oncology · 2021
- WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition
WHO · World Health Organization · 2021
- Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
ESMO · European Society for Medical Oncology · 2020
- Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
ESMO · European Society for Medical Oncology · 2020
- Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
ESMO · European Society for Medical Oncology · 2020
- Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines
ESMO · European Society for Medical Oncology · 2018
Belgium· 4
- Evaluation of breast cancer screening in Belgium
KCE · Belgian Health Care Knowledge Centre · 2026 · health technology assessment
- Guideline on the management of rectal cancer
KCE · Belgian Health Care Knowledge Centre · 2016
- Colon cancer: diagnosis, treatment and follow-up
KCE · Belgian Health Care Knowledge Centre · 2014
- Informed choice on breast cancer screening: messages to support informed decision
KCE · Belgian Health Care Knowledge Centre · 2014 · recommendation
Denmark· 4
- Oncological Treatment of Inoperable Metastatic Melanoma
DMCG · Dansk Melanom Gruppe (Danske Multidisciplinaere Cancer Grupper) · 2025
- Curative Radiotherapy for Prostate Cancer
DMCG · Dansk Prostata Cancer Gruppe (Danske Multidisciplinaere Cancer Grupper) · 2025
- Breast Cancer: Follow-up
DMCG · Danish Breast Cancer Group (Danske Multidisciplinaere Cancer Grupper) · 2025
- Treatment of Acute Myeloid Leukaemia (AML)
DMCG · Akut Leukaemi Gruppen (Danske Multidisciplinaere Cancer Grupper) · 2024
France· 9
- Pilot Programme for Organized Lung Cancer Screening — Summary of Retained Proposals
INCa · Institut National du Cancer · 2024 · recommendation
- Cutaneous Melanomas — From Diagnosis to Follow-up (General Practitioner Practice Tool)
INCa · Institut National du Cancer · 2024 · good practice guide
- Targeted Biopsies in the Diagnosis of Prostate Cancer
HAS · Haute Autorité de Santé · 2023 · recommendation
- Patients with Cutaneous or Mucosal Melanoma: Indications for Molecular Testing for Prescribing Precision Treatments
INCa · Institut National du Cancer · 2023 · recommendation
- National Organizational Reference Framework: Supportive Oncology Care for Adult Cancer Patients
INCa · Institut National du Cancer · 2021 · good practice guide
- Colorectal Cancer: Screening and Prevention Modalities in Subjects at High and Very High Risk
HAS · Haute Autorité de Santé · 2017 · recommendation
- Women Carrying a BRCA1 or BRCA2 Mutation: Early Detection of Breast and Adnexal Cancer and Risk-Reduction Strategies (Synthesis)
INCa · Institut National du Cancer · 2017 · recommendation
- Breast Cancer Screening According to Risk Factor
HAS · Haute Autorité de Santé · 2014 · recommendation
- Colorectal Cancer Screening and Prevention (Health Examination Centres Reference Document)
HAS · Haute Autorité de Santé · 2013 · good practice guide
Germany· 10
- Colorectal Cancer
LL-Onko · Leitlinienprogramm Onkologie · 2026
- Supportive Therapy in Oncology Patients
LL-Onko · Leitlinienprogramm Onkologie · 2026
- Diagnosis, Therapy and Follow-up of Malignant Ovarian Tumors
LL-Onko · Leitlinienprogramm Onkologie · 2026
- Early Detection, Diagnosis, Therapy and Follow-up of Breast Cancer
LL-Onko · Leitlinienprogramm Onkologie · 2025
- Prostate Cancer
LL-Onko · Leitlinienprogramm Onkologie · 2025
- Prevention, Diagnosis, Therapy and Follow-up of Lung Cancer
LL-Onko · Leitlinienprogramm Onkologie · 2025
- Diagnosis and Therapy of Adenocarcinomas of the Stomach and Esophagogastric Junction
LL-Onko · Leitlinienprogramm Onkologie · 2025
- Exocrine Pancreatic Cancer
LL-Onko · Leitlinienprogramm Onkologie · 2024
- Diagnosis, Therapy and Follow-up of Melanoma
LL-Onko · Leitlinienprogramm Onkologie · 2020
- Palliative Care for Patients with Incurable Cancer
LL-Onko · Leitlinienprogramm Onkologie · 2020
Ireland· 3
- Diagnosis, Staging and Treatment of Patients with Breast Cancer — National Clinical Guideline No. 7
NCEC · National Clinical Effectiveness Committee, Department of Health · 2024
- Diagnosis, Staging and Treatment of Patients with Lung Cancer: National Clinical Guideline No. 16
NCCP · National Cancer Control Programme, Health Service Executive · 2017
- Diagnosis, Staging and Treatment of Patients with Breast Cancer: National Clinical Guideline No. 7
NCCP · National Cancer Control Programme, Health Service Executive · 2015
Italy· 2
- Lung neoplasms
SNLG · Sistema Nazionale Linee Guida - Istituto Superiore di Sanita · 2024
- Melanoma
AIOM · Associazione Italiana di Oncologia Medica · 2023
Netherlands· 8
- Colorectal Cancer
FMS · Federatie Medisch Specialisten · 2026
- Melanoma
FMS · Federatie Medisch Specialisten · 2026
- Breast Cancer
FMS · Federatie Medisch Specialisten · 2025
- Non-Small Cell Lung Cancer
FMS · Federatie Medisch Specialisten · 2025
- Gastric Cancer
FMS · Federatie Medisch Specialisten · 2025
- Esophageal Cancer
FMS · Federatie Medisch Specialisten · 2024
- Pancreatic Cancer
FMS · Federatie Medisch Specialisten · 2019
- Prostate Cancer
FMS · Federatie Medisch Specialisten · 2016
Norway· 4
- National Action Programme with Guidelines for Colorectal Cancer
Helsedir · Norwegian Directorate of Health · 2026
- National Action Programme with Guidelines for Breast Cancer
Helsedir · Norwegian Directorate of Health · 2026
- National action programme with guidelines for breast cancer - adjuvant endocrine therapy
Hdir · Norwegian Directorate of Health · 2026
- National Action Programme with Guidelines for Prostate Cancer
Helsedir · Norwegian Directorate of Health · 2025
Poland· 3
- Clinical Practice Guideline Recommendation No. 178/2025 on Lung Cancer Screening with Low-Dose Computed Tomography
AOTMiT · Agencja Oceny Technologii Medycznych i Taryfikacji · 2025 · recommendation
- Guidelines for diagnostic and therapeutic management of patients with skin cancer (version 2, November 2024)
NIO-PIB / KOM · Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie — Państwowy Instytut Badawczy, Krajowy Ośrodek Monitorujący · 2024
- Diagnostic and Therapeutic Guidelines for Breast Cancer
PTOK · Polskie Towarzystwo Onkologii Klinicznej · 2020
Portugal· 3
- Population-Based Colorectal Cancer Screening Programme
DGS · Direção-Geral da Saúde · 2025
- Population-Based Breast Cancer Screening Programme
DGS · Direção-Geral da Saúde · 2024
- Breast Carcinoma: Adjuvant Treatment
DGS · Direcao-Geral da Saude · 2011
Spain· 1
- GEICAM Clinical Practice Guideline for the Diagnosis and Treatment of Metastatic Breast Cancer
GuiaSalud · GuíaSalud — Clinical Practice Guidelines in the Spanish National Health System · 2026
Sweden· 2
- National Care Programme for Breast Cancer
RCC · Regional Cancer Centres in Collaboration · 2025
- National Care Programme for Prostate Cancer - Short Version for General Practitioners
RCC · Regional Cancer Centres in Collaboration · 2025
United Kingdom· 8
- Suspected cancer: recognition and referral
NICE · National Institute for Health and Care Excellence · 2025
- Early and locally advanced breast cancer: diagnosis and management
NICE · National Institute for Health and Care Excellence · 2025
- Advanced breast cancer: diagnosis and treatment
NICE · National Institute for Health and Care Excellence · 2025
- Lung cancer: diagnosis and management
NICE · National Institute for Health and Care Excellence · 2024
- Melanoma: assessment and management
NICE · National Institute for Health and Care Excellence · 2022
- Colorectal cancer
NICE · National Institute for Health and Care Excellence · 2021
- Prostate cancer: diagnosis and management
NICE · National Institute for Health and Care Excellence · 2021
- Pancreatic cancer in adults: diagnosis and management
NICE · National Institute for Health and Care Excellence · 2018
Looking for a specific country? Belgium, Denmark, France, Germany, Ireland, Italy.